BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31756763)

  • 1. The Effect of Intramuscular 17α-Hydroxyprogesterone in Women Screened for Shortened Cervical Length.
    Wood SL; Williams BN; Szychowski JM; Owen J
    Am J Perinatol; 2020 Jun; 37(7):659-665. PubMed ID: 31756763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of 17α-hydroxyprogesterone caproate on preterm birth in women with an ultrasound-indicated cerclage.
    Rafael TJ; Mackeen AD; Berghella V
    Am J Perinatol; 2011 May; 28(5):389-94. PubMed ID: 21380984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerclage for the prevention of preterm birth in high risk women receiving intramuscular 17-α-hydroxyprogesterone caproate.
    Szychowski JM; Berghella V; Owen J; Hankins G; Iams JD; Sheffield JS; Perez-Delboy A; Wing DA; Guzman ER;
    J Matern Fetal Neonatal Med; 2012 Dec; 25(12):2686-9. PubMed ID: 22889234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17-alpha-hydroxyprogesterone caproate for the prevention of preterm birth in women with prior preterm birth and a short cervical length.
    Berghella V; Figueroa D; Szychowski JM; Owen J; Hankins GD; Iams JD; Sheffield JS; Perez-Delboy A; Wing DA; Guzman ER;
    Am J Obstet Gynecol; 2010 Apr; 202(4):351.e1-6. PubMed ID: 20350641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of 17-α-hydroxyprogesterone caproate on preterm birth prevention in women with history-indicated cerclage.
    Mackeen AD; Rafael TJ; Zavodnick J; Berghella V
    Am J Perinatol; 2013 Oct; 30(9):755-8. PubMed ID: 23341330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of midtrimester short cervix interventions is conditional on intraamniotic inflammation.
    Kiefer DG; Peltier MR; Keeler SM; Rust O; Ananth CV; Vintzileos AM; Hanna N
    Am J Obstet Gynecol; 2016 Feb; 214(2):276.e1-276.e6. PubMed ID: 26364833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate.
    Stetson B; Hibbard JU; Wilkins I; Leftwich H
    Obstet Gynecol; 2016 Nov; 128(5):983-988. PubMed ID: 27741201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gestational age at initiation of 17-alpha hydroxyprogesterone caproate and recurrent preterm birth.
    Ning A; Vladutiu CJ; Dotters-Katz SK; Goodnight WH; Manuck TA
    Am J Obstet Gynecol; 2017 Sep; 217(3):371.e1-371.e7. PubMed ID: 28526452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous preterm birth in African-American and Caucasian women receiving 17α-hydroxyprogesterone caproate.
    Timofeev J; Singh J; Istwan N; Rhea D; Driggers RW
    Am J Perinatol; 2014 Jan; 31(1):55-60. PubMed ID: 23456908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical length, cervical dilation, and gestational age at cerclage placement and the risk of preterm birth in women undergoing ultrasound or exam indicated Shirodkar cerclage.
    Bigelow CA; Naqvi M; Namath AG; Ali M; Fox NS
    J Matern Fetal Neonatal Med; 2020 Aug; 33(15):2527-2532. PubMed ID: 30486708
    [No Abstract]   [Full Text] [Related]  

  • 11. Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis.
    Conde-Agudelo A; Romero R; Da Fonseca E; O'Brien JM; Cetingoz E; Creasy GW; Hassan SS; Erez O; Pacora P; Nicolaides KH
    Am J Obstet Gynecol; 2018 Jul; 219(1):10-25. PubMed ID: 29630885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerclage for sonographic short cervix in singleton gestations without prior spontaneous preterm birth: systematic review and meta-analysis of randomized controlled trials using individual patient-level data.
    Berghella V; Ciardulli A; Rust OA; To M; Otsuki K; Althuisius S; Nicolaides KH; Roman A; Saccone G
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):569-577. PubMed ID: 28295722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial.
    Price JT; Vwalika B; Freeman BL; Cole SR; Saha PT; Mbewe FM; Phiri WM; Peterson M; Muyangwa D; Sindano N; Mwape H; Smithmyer ME; Kasaro MP; Rouse DJ; Goldenberg RL; Chomba E; Stringer JSA
    Lancet HIV; 2021 Oct; 8(10):e605-e613. PubMed ID: 34509197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical cerclage for singleton pregnant patients on vaginal progesterone with progressive cervical shortening.
    Enakpene CA; DiGiovanni L; Jones TN; Marshalla M; Mastrogiannis D; Della Torre M
    Am J Obstet Gynecol; 2018 Oct; 219(4):397.e1-397.e10. PubMed ID: 30017683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of preterm birth with pessary in singletons (PoPPS): randomized controlled trial.
    Dugoff L; Berghella V; Sehdev H; Mackeen AD; Goetzl L; Ludmir J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):573-579. PubMed ID: 28940481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of different progesterone preparations with preterm birth prevention.
    Krispin E; Hadar E; Chen R; Wiznitzer A; Kaplan B
    J Matern Fetal Neonatal Med; 2019 Oct; 32(20):3452-3457. PubMed ID: 29699436
    [No Abstract]   [Full Text] [Related]  

  • 17. Indomethacin administration at the time of ultrasound-indicated cerclage: is there an association with a reduction in spontaneous preterm birth?
    Visintine J; Airoldi J; Berghella V
    Am J Obstet Gynecol; 2008 Jun; 198(6):643.e1-3. PubMed ID: 18221923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical Cerclage versus Vaginal Progesterone for Management of Short Cervix in Low-Risk Women.
    Wood AM; Dotters-Katz SK; Hughes BL
    Am J Perinatol; 2019 Jan; 36(2):111-117. PubMed ID: 30112757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial.
    Senat MV; Porcher R; Winer N; Vayssière C; Deruelle P; Capelle M; Bretelle F; Perrotin F; Laurent Y; Connan L; Langer B; Mantel A; Azimi S; Rozenberg P;
    Am J Obstet Gynecol; 2013 Mar; 208(3):194.e1-8. PubMed ID: 23433324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short cervical length dilemma.
    Suhag A; Berghella V
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):241-54. PubMed ID: 26002164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.